HK1046911A1 - 經穩定的病毒外膜蛋白質及其使用 - Google Patents

經穩定的病毒外膜蛋白質及其使用

Info

Publication number
HK1046911A1
HK1046911A1 HK02107688.0A HK02107688A HK1046911A1 HK 1046911 A1 HK1046911 A1 HK 1046911A1 HK 02107688 A HK02107688 A HK 02107688A HK 1046911 A1 HK1046911 A1 HK 1046911A1
Authority
HK
Hong Kong
Prior art keywords
envelope proteins
viral envelope
stabilized viral
stabilized
proteins
Prior art date
Application number
HK02107688.0A
Other languages
English (en)
Inventor
M Binley James
Schuelke Norbert
C Olson William
J Maddon Paul
P Moore John
Original Assignee
Progenics Pharm Inc
Aaron Diamond Aids Res Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progenics Pharm Inc, Aaron Diamond Aids Res Center filed Critical Progenics Pharm Inc
Publication of HK1046911A1 publication Critical patent/HK1046911A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK02107688.0A 1999-06-25 2002-10-23 經穩定的病毒外膜蛋白質及其使用 HK1046911A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34099299A 1999-06-25 1999-06-25
PCT/US2000/017267 WO2001000648A1 (en) 1999-06-25 2000-06-23 Stabilized viral envelope proteins and uses thereof

Publications (1)

Publication Number Publication Date
HK1046911A1 true HK1046911A1 (zh) 2003-01-30

Family

ID=23335807

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107688.0A HK1046911A1 (zh) 1999-06-25 2002-10-23 經穩定的病毒外膜蛋白質及其使用

Country Status (6)

Country Link
EP (1) EP1198468A4 (zh)
JP (1) JP2003509013A (zh)
AU (1) AU782123B2 (zh)
CA (1) CA2370517A1 (zh)
HK (1) HK1046911A1 (zh)
WO (1) WO2001000648A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710173B1 (en) 1999-06-25 2004-03-23 Progenics Pharmaceuticals, Inc. Stabilized viral envelope proteins and uses thereof
US20050089526A1 (en) * 2001-09-06 2005-04-28 Moore John P. Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
EP1463521A4 (en) * 2001-12-17 2009-06-24 Us Gov Health & Human Serv GP41 INHIBITORS
US20060051373A1 (en) * 2002-04-05 2006-03-09 Olson William C Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods
KR20060041179A (ko) * 2003-06-12 2006-05-11 박스젠 인코포레이티드 비정상적인 이황화물 구조를 지닌 ｈｉｖ-1 외피 당단백질
KR100560468B1 (ko) 2003-09-16 2006-03-13 삼성에스디아이 주식회사 화상 표시 장치와 그 표시 패널
WO2007107090A1 (en) * 2006-03-17 2007-09-27 Huawei Technologies Co., Ltd. Method and apparatus for enabling soft handoff in an ofdma-based communication system
CA2667358A1 (en) 2006-10-23 2008-05-29 Progenics Pharmaceuticals, Inc. Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric complexes, and uses thereof
US20150183835A1 (en) * 2012-06-18 2015-07-02 Novartis Ag Stabilized gp120
CA3116175A1 (en) 2018-10-17 2020-04-23 Glaxosmithkline Biologicals Sa Modified cytomegalovirus proteins and stabilized complexes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU641814B2 (en) * 1990-09-25 1993-09-30 Peptech (Uk) Limited Aids therapy and vaccine
US5869624A (en) * 1993-03-26 1999-02-09 Progenics Pharmaceuticals, Inc. HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof

Also Published As

Publication number Publication date
AU782123B2 (en) 2005-07-07
EP1198468A1 (en) 2002-04-24
EP1198468A4 (en) 2003-07-30
AU5884200A (en) 2001-01-31
WO2001000648A1 (en) 2001-01-04
JP2003509013A (ja) 2003-03-11
CA2370517A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
PL346346A1 (en) Cyclic prosaposin-derived peptides and uses thereof
PL366621A1 (en) Core-glycosylated hcv envelope proteins
EP1185545A4 (en) CD4-INDEPENDENT HIV ENVELOPE PROTEINS AS VACCINE AND THERAPEUTICA
GB9930519D0 (en) Uses of transport proteins
HK1046911A1 (zh) 經穩定的病毒外膜蛋白質及其使用
EP1357186A4 (en) NEW PROTEINS AND CORRESPONDING DNA
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
EP1186615A4 (en) PROTEIN AND DNA OF THIS PROTEIN
GB9918155D0 (en) Proteins and peptides
EP1239039A4 (en) NEW POLYPEPTIDE AND ENCODING DNA
EP1113777A4 (en) NOVEL HEPATITIS C VIRUS PEPTIDES AND USES THEREOF
HUP0201660A2 (en) Novel polypeptide and dna thereof
IL148446A0 (en) Iren protein, its preparation and use
AU2136401A (en) P450rai-2 and related proteins
HUP0202270A2 (en) Antitumor antibodies, proteins, and uses thereof
PL350549A1 (en) Insect viral vectors and uses thereof
GB9921631D0 (en) Combined card and envelope
AU2225401A (en) Novel protein and dna thereof
EP1293510A4 (en) POLYPEPTIDE AND ITS DNA
IL131785A0 (en) Chimeric envelope proteins viruses containing same and uses thereof
AU1734800A (en) (bartonella) proteins and uses thereof
GB9927353D0 (en) Virus preparation and use
NZ513920A (en) Novel proteins and uses thereof
EP1234032A4 (en) NUCLEIC ACID AND POLYPEPTIDE
ZA200007318B (en) Particles of HCV envelope proteins: use for vaccination.